Increased risk of death associated with the use of proton‐pump inhibitors in patients with dementia and controls – a pharmacoepidemiological claims data analysis

BACKGROUND AND PURPOSE: The use of proton‐pump inhibitors (PPIs) was reported to be associated with increased mortality risk and has been proposed as a potential risk factor for neurodegenerative diseases. We aimed to assess the impact of PPI use on survival in patients with dementia as compared wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cetin, H., Wurm, R., Reichardt, B., Tomschik, M., Silvaieh, S., Parvizi, T., König, T., Erber, A., Schernhammer, E., Stamm, T., Stögmann, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Dementia and Cognitive Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496707/
https://www.ncbi.nlm.nih.gov/pubmed/32281706
http://dx.doi.org/10.1111/ene.14252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496707/
https://www.ncbi.nlm.nih.gov/pubmed/32281706
http://dx.doi.org/10.1111/ene.14252

Ejemplares similares